Home
What we do
What we do

Cisiv develops an integrated platform specifically designed for real-world late phase research.
Technical solutions

Real world electronic data capture

Patient centric solutions

eConsent

Surveys

Expanded and managed access programmes
Study types

Observational studies

Post approval safety studies (PASS)

Registries

Retrospective chart reviews
Who we work with
Who we work with

At Cisiv we work with a range of different research organisations and life science companies across the globe.

Biotech and pharma

Contract research organisations (CROs)

MedTech

Patient advocacy groups

Academia
About
About Cisiv

Cisiv is a pioneer in technology for collating and curating real world data.

Our team

Our values

Our history

Why Cisiv?
Learning Centre
Careers
Contact

Category: Webinars

Webinars

How to develop an integrated evidence strategy for rare disease clinical development.

Recorded: 15th May 2024 This webinar is aimed at Pharma and Biotech professionals who work on rare disease drug development

May 17, 2024

Webinars

RWD and HTA – from guidelines to real-world impact

Recorded: December 11 2023 In recent years, we have witnessed the emergence of frameworks in support of the use of

January 12, 2024

Webinars

How to successfully operationalise real world data collection alongside expanded access programmes

Recorded: 5 October 2023 An expanded access programme is a legislative framework, used by both the European Medicines Agency (EMA) and the Food and

December 1, 2023

Filter by Technical solutions

Filter by Study types

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Others

What we do

Technical solutions

Study types

Who we work with

About Cisiv

Category: Webinars

How to develop an integrated evidence strategy for rare disease clinical development.

RWD and HTA – from guidelines to real-world impact

How to successfully operationalise real world data collection alongside expanded access programmes

Filter by Technical solutions

Filter by Study types

Contact Us

What we do

Get in touch

Get in touch

What we do

Technical solutions

Study types

Who we work with

About Cisiv

Category: Webinars

How to develop an integrated evidence strategy for rare disease clinical development.

RWD and HTA – from guidelines to real-world impact

How to successfully operationalise real world data collection alongside expanded access programmes

Filter by Technical solutions

Filter by Study types

Contact Us

What we do

Get in touch

Get in touch

Speak to an expert...